For this assay C2C12 cells were seeded in black Advanced TC 96-well microplates (Greiner Bio-One, Kremsmünster, Austria). Cell culture and treatments with recombinant proteins were performed in both proliferation and differentiation stages according to the above-described protocols (Figures 1A,B). Immunofluorescence staining and image analysis were performed as described before (Alvarez et al., 2020). At 24 h after treatment with the recombinant proteins, cells were washed, fixed for 1 h with cold 4% paraformaldehyde, permeabilized for 5 min and blocked with 1% bovine serum albumin for 30 min. The primary antibodies rabbit anti-mouse Pax7, Myf5, MyoD (1:1000; Santa Cruz Biotechnology, Dallas, TX, United States), and myogenin (1:2000; Sigma-Aldrich) were added and incubated overnight at 4°C. After washing (three times), the cells were incubated with a Hoechst DNA-specific stain (1:3000; Thermo Fisher Scientific, Waltham, MA, United States) and anti-rabbit secondary antibodies conjugated to Alexa Fluor 488, 568, 647, and 594 respectively (1:1000; Thermo Fisher Scientific) at room temperature for 1 h. Finally, the plates were subjected to high content imaging analysis on MetaXpress High-Content Image Acquisition & Analysis Software (Molecular Devices). The system was used to acquire 16 images per well at 20× magnifications, and the quantitative data shown represent the mean fluorescence intensity of each protein, corrected with the secondary antibody control.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.